Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris‐Oliver, Vincent Vandecaveye, Jordi Abril‐Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhöfler, Agavni Mesropian, Júlia Huguet‐Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, Antonio D’Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwälder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet (2024). Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Journal of Hepatology, DOI: 10.1016/j.jhep.2024.12.016.
Article344 days agoBaseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Sirish Dharmapuri, Umut Özbek, Hiren Jethra, Tomi Jun, Thomas U. Marron, Anwaar Saeed, Yi‐Hsiang Huang, Mahvish Muzaffar, Matthias Pinter, Lorenz Balcar, Claudia Angela Maria Fulgenzi, Suneetha Amara, Arndt Weinmann, Nicola Personeni, Bernhard Scheiner, Tiziana Pressiani, Musharraf Navaid, Bertram Bengsch, Sonal Paul, Uqba Khan, Dominik Bettinger, Naoshi Nishida, Yehia I. Mohamed, Arndt Vogel, Anuhya Gampa, James Korolewicz, Antonella Cammarota, Ahmed O. Kaseb, Peter R. Galle, Anjana Pillai, Yinghong Wang, Alessio Cortellini, Masatoshi Kudo, Antonio D’Alessio, Lorenza Rimassa, David J. Pinato, Celina Ang (2023). Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. , 15(11), DOI: https://doi.org/10.4251/wjgo.v15.i11.1900.
Article6 days agoPD-16 Atezolizumab plus bevacizumab is associated with improved survival outcomes in HCC patients with Child-Pugh B dysfunction compared to best supportive therapy
Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Bernhard Scheiner, Celina Ang, Brooke Wietharn, Matthias Pinter, Naoshi Nishida, Alessandro Parisi, Yi‐Hsiang Huang, Dominik Bettinger, Arndt Vogel, M. Silletta, Martin Schönlein, Peter R. Galle, Masatoshi Kudo, Amit G. Singal, Alessio Cortellini, Hong Jae Chon, Bernardo Stefanini, E. Giannini, David J. Pinato (2023). PD-16 Atezolizumab plus bevacizumab is associated with improved survival outcomes in HCC patients with Child-Pugh B dysfunction compared to best supportive therapy. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.04.043.
Article6 days agoNeutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).
Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Hong Jae Chon, Masatoshi Kudo, Martin Schönlein, Johann von Felden, Brooke Wietharn, Samuel Phen, Bernhard Scheiner, Lorenz Balcar, Yi‐Hsiang Huang, Tiziana Pressiani, Gianluca Masi, Abdul Rafeh Naqash, Dominik Bettinger, Arndt Vogel, Peter R. Galle, Vince Gaillard, Celina Ang (2023). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).. , 41(4_suppl), DOI: https://doi.org/10.1200/jco.2023.41.4_suppl.504.
Article6 days agoFeasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction
Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Bernhard Scheiner, Naoshi Nishida, Celina Ang, Thomas U. Marron, Linda Y. Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Matthias Pinter, Rohini Sharma, Jaekyung Cheon, Yi‐Hsiang Huang, Pei‐Chang Lee, Samuel Phen, Anuhya Gampa, Anjana Pillai, Andrea Napolitano, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Robert Thimme, Arndt Vogel, Martin Schoenlein, Kornelius Schulze, Johann von Felden, Henning Wege, Peter R. Galle, Mario Pirisi, Joong‐Won Park, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Alessio Cortellini, Hong Jae Chon, Giorgia Ghittoni, Calogero Cammà, Benedetta Stefanini, Franco Trevisani, Edoardo G. Giannini, David J. Pinato (2023). Feasibility of systemic anti-cancer therapy as an alternative to best supportive care in patients with advanced HCC and Child-Pugh B liver dysfunction. , 78, DOI: https://doi.org/10.1016/s0168-8278(23)01390-9.
Article6 days ago